Bruker Corporation is a developer, manufacturer and distributor of scientific instruments and analytical and diagnostic solutions. Its BSI BioSpin segment designs, manufactures, and distributes enabling life science tools based on magnetic resonance technology. Its BSI CALID segment designs, manufactures and distributes life science mass spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. Its BSI Nano segment designs, manufactures and distributes advanced X-ray instruments, atomic force microscopy instrumentation, advanced fluorescence optical microscopy instruments. Its Bruker Energy & Supercon Technologies (BEST) segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and big science research. It also offers advanced research Raman microscopy systems. Its product lines include nCounter, CosMx, GeoMx and AtoMx.

Employees

9,707

Sector

Advanced Medical Equipment & Technology

Calendar

2024-10-30 - Q3 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
24-09-17	65.11 $	-0.26%	298,320
24-09-16	65.28 $	-0.58%	963,113
24-09-13	65.66 $	+1.44%	805,408
24-09-12	64.73 $	+1.16%	1,125,447
24-09-11	63.99 $	+1.06%	785,132

Delayed Quote Nasdaq, September 17, 2024 at 11:43 am

More quotes

Income Statement and Estimates

More financial data

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

65.28USD

Average target price

79.74USD

Spread / Average Target

+22.15%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Real-time Estimate Cboe BZX Other stock markets 11:56:46 2024-09-17 EDT			5-day change	1st Jan Change
65.18 ^USD	-0.15%		+2.78%	-11.43%

09-06	Transcript : Bruker Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:00 AM
09-04	Transcript : Bruker Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM

Capitalization	9.88B 13.43B	P/E ratio 2024 *	47x	P/E ratio 2025 *	29.8x
Enterprise value	10.96B 14.9B	EV / Sales 2024 *	3.45x	EV / Sales 2025 *	2.98x
Free-Float	56.61%	Yield 2024 *	0.31%	Yield 2025 *	0.31%

Transcript : Bruker Corporation Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-06-2024 10:00 AM	09-06
Transcript : Bruker Corporation Presents at Wells Fargo 2024 Healthcare Conference, Sep-04-2024 10:15 AM	09-04
Bruker Announces Successful Installation of 1.2 GHz Avance NMR Spectrometer at the Korea Basic Science Institute	08-13	CI
Bruker Keeps Quarterly Dividend at $0.05 a Share, Payable Sept. 16 to Stockholders of Record Sept. 2	08-12	MT
Bruker Corporation Announces Quarterly Cash Dividend, Payable on September 16, 2024	08-12	CI
Bruker Acquires Minority Stake in NovAliX	08-07	MT
Philip Ma Resigns from Board of Bruker Corporation	08-07	CI
Bruker Corporation and NovAliX Collaborate Strategically to Develop Novel Drug Discovery Technologies and Methods	08-07	CI
NovAliX SAS announced that it has received funding from Bruker Corporation	08-06	CI
Sector Update: Health Care Stocks Flat to Higher Premarket Tuesday	08-06	MT
Transcript : Bruker Corporation, Q2 2024 Earnings Call, Aug 06, 2024	08-06
Bruker Q2 Adjusted Earnings, Revenue Rise; Fiscal 2024 Outlook Revised	08-06	MT
Earnings Flash (BRKR) BRUKER CORPORATION Posts Q2 Revenue $800.7M, vs. Street Est of $797.8M	08-06	MT

Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	07-09	MT
Stifel Adjusts Price Target on Bruker to $77 From $81, Maintains Hold Rating	05-20	MT
Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	04-10	MT
UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating	03-01	MT
UBS Adjusts Bruker Price Target to $94 From $86, Maintains Buy Rating	02-15	MT

Bruker Corporation Stock

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Valuation: Bruker Corporation

Chart: Bruker Corporation

Latest news: Bruker Corporation

Last Transcript: Bruker Corporation

Analysts' recommendations: Bruker Corporation

Press Releases: Bruker Corporation

News in other languages: Bruker Corporation

Quotes and Performance

Course Extremes

Managers and Directors: Bruker Corporation

ETFs: Bruker Corporation

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Ratings

Analysts' Consensus

Quarterly earnings, Rate of surprise

Bruker Corporation to Present at Upcoming Investor Conferences	08-26	AQ
Bruker Corporation to Present at Upcoming Investor Conferences	08-23	BU
Bruker Announces Successful Installation of 1.2 GHz Avance® NMR Spectrometer at the Korea Basic Science Institute (KBSI)	08-13	BU
Bruker Announces Quarterly Dividend	08-12	BU
Bruker Announces Strategic Minority Investment in NovAliX	08-07	BU

Momentum Picks Q2 2023: vijf aandelen voor de lente	23-04-20
Momentum Picks Q2 2023: 5 Aktien für den Frühling	23-04-06
Morning Briefing - International	23-04-04
Momentum Picks Q2 2023: 5 azioni per la primavera	23-04-03
Momentum Picks 2T 2023: 5 acciones para la primavera	23-03-31

1 day	-0.15%
1 week	+2.78%
Current month	-3.14%
3 months	+0.35%
6 months	-29.28%
Current year	-11.43%

Director	Title	Age	Since
Frank Laukien CEO	Chief Executive Officer	64	91-01-31
Gerald Herman DFI	Director of Finance/CFO	66	16-11-30
Justin Ward IRC	Investor Relations Contact	-	21-12-31

Manager	Title	Age	Since
William Linton BRD	Director/Board Member	77	00-01-31
Frank Laukien CEO	Chief Executive Officer	64	91-01-31
Richard Packer BRD	Director/Board Member	66	07-04-30

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
BRUKER CORPORATION	-0.15%	+2.78%	+0.11%	-21.92%	9.88B
THERMO FISHER SCIENTIFIC INC.	+0.01%	-1.57%	+21.01%	+2.95%	235B
DANAHER CORPORATION	-0.81%	-0.23%	+8.01%	-15.54%	199B
INTUITIVE SURGICAL, INC.	-0.68%	+0.55%	+63.30%	+40.82%	175B
BOSTON SCIENTIFIC CORPORATION	-1.45%	-0.75%	+55.55%	+85.80%	123B
SIEMENS HEALTHINEERS AG	+1.19%	-0.20%	+10.45%	-13.49%	61.32B
EDWARDS LIFESCIENCES CORPORATION	+2.86%	+5.78%	-2.63%	-40.53%	41.78B
AGILENT TECHNOLOGIES, INC.	+0.39%	+0.80%	+23.47%	-20.01%	39.74B
GE HEALTHCARE TECHNOLOGIES INC.	+1.49%	+2.88%	+32.80%	-	39.57B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-0.20%	-4.31%	-16.42%	-29.48%	39.5B
Average	+0.25%	+1.10%	+19.56%	-1.27%	96.33B
Weighted average by Cap.	-0.22%	+1.08%	+27.53%	+11.45%

	2024 *	2025 *
Net sales	3.4B 4.62B	3.72B 5.06B
Net income	256M 348M	382M 519M
Net Debt	1.85B 2.51B	1.21B 1.64B